Figure 2.
NRM stratified by day 28 RR. The cumulative incidence of NRM within 6 months stratified by day 28 RR in the JSTCT validation set for primary treatment (A), MAGIC validation set for primary treatment (B), JSTCT validation set for second-line treatment (C), and MAGIC validation set for second-line treatment (D). The pie chart represents the proportion of each risk group.